Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response.
Sundahl N, De Wolf K, Rottey S, Decaestecker K, De Maeseneer D, Meireson A, Goetghebeur E, Fonteyne V, Verbeke S, De Visschere P, Reynders D, Van Gele M, Brochez L, Ost P. Sundahl N, et al. Among authors: de maeseneer d, de wolf k, de visschere p. J Transl Med. 2017 Jun 29;15(1):150. doi: 10.1186/s12967-017-1251-3. J Transl Med. 2017. PMID: 28662677 Free PMC article. Clinical Trial.
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial.
De Wolf K, Rottey S, Vermaelen K, Decaestecker K, Sundahl N, De Lobel L, Goetghebeur E, De Meerleer G, Lumen N, Fonteyne V, De Maeseneer D, Ost P. De Wolf K, et al. Among authors: de maeseneer d, de lobel l, de meerleer g. Radiat Oncol. 2017 Sep 22;12(1):157. doi: 10.1186/s13014-017-0893-x. Radiat Oncol. 2017. PMID: 28938918 Free PMC article. Clinical Trial.
Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial.
Berwouts D, De Wolf K, Lambert B, Bultijnck R, De Neve W, De Lobel L, Jans L, Goetghebeur E, Speleers B, Olteanu LA, Madani I, Goethals I, Ost P. Berwouts D, et al. Among authors: de wolf k, de lobel l, de neve w. Radiother Oncol. 2015 May;115(2):272-8. doi: 10.1016/j.radonc.2015.04.022. Epub 2015 May 14. Radiother Oncol. 2015. PMID: 25981049 Clinical Trial.
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18 F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trial.
Berwouts D, De Wolf K, De Neve W, Olteanu LA, Lambert B, Speleers B, Goethals I, Madani I, Ost P. Berwouts D, et al. Among authors: de wolf k, de neve w. J Med Imaging Radiat Oncol. 2017 Feb;61(1):124-132. doi: 10.1111/1754-9485.12507. Epub 2016 Aug 16. J Med Imaging Radiat Oncol. 2017. PMID: 27527354 Clinical Trial.
Guess what! Angiosarcoma of the face and scalp.
Verleysen A, Dewolf K, Geerts ML, Naeyaert JM. Verleysen A, et al. Eur J Dermatol. 2000 Jul-Aug;10(5):403-4. Eur J Dermatol. 2000. PMID: 11023338 No abstract available.
29 results